Breast Implant–Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?
Abstract
Background Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a locally aggressive T-cell lymphoma that can develop following breast implantation. In 2017, and updated in 2019, the National Comprehensive Cancer Network (NCCN) recommended total capsulectomy with implant removal as definitive therapy. Objectives The aim of this study was to evaluate the US insurance coverage for the management of BIA-ALCL and compare it to the...
Paper Details
Title
Breast Implant–Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?
Published Date
Apr 15, 2021
Journal
Volume
41
Issue
12
Pages
NP1943 - NP1949
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History